ArticleBreast cancer research and treatment2021

Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES.

Young-Hyuck Im et al.PubMed ↗Publisher ↗

No numbers read from the abstract.